Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...
Path to Prevention (P2P) is a Phase 2A platform trial that leverages Parkinson’s Precision Medicine Initiative (PPMI) infrastructure to evaluate investigational products in participants with neuronal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results